Top

BY Julie Penne

MD Anderson Cancer Center and UnitedHealthcare have launched a pilot program to explore a new cancer care payment model for head and neck cancers that focuses on quality patient care and outcomes. The collaboration is among the first using bundled payments in a large, comprehensive cancer center.

The bundled payment method reimburses a care provider or hospital for a defined episode of care under a single fee or payment. This is...

BY Ron Gilmore

Study results of CD19-directed chimeric antigen receptor (CAR) therapy using the Sleeping Beauty non-viral transduction system to modify T...

BY Laura Sussman

In what’s believed to be one of the largest population-based studies of Oncotype DX ever conducted, researchers at MD Anderson Cancer Center...

BY MD Anderson staff

The Food and Drug Administration’s (FDA) approval of a new vaccine that targets five additional strains of human papillomavirus (HPV) fortifies a proven cancer-prevention weapon, according to Ronald DePinho, M.D., president of MD Anderson Cancer Center.

The FDA greenlighted use of Gardasil 9 for the prevention of certain cancers caused by nine HPV strains – five more than its predecessor, Gardasil. The FDA said Gardasil 9 has the...

HPV vaccine cancer prevention

BY Ron Gilmore

It’s hard to believe, but there are similarities between bean sprouts and human cancer.

In bean sprouts, a collection of amino acids...

BY Ron Gilmore

Molecules known as long non-coding RNAs (lncRNAs) have been implicated in breast cancer but exactly why they cause metastasis and tumor growth...

BY Laura Sussman

In the next 15 years, more than one in 10 colon cancers and nearly one in four rectal cancers will be diagnosed in patients younger than the...

BY Ron Gilmore

Scientists have found that altering members of the p53 gene family, known as tumor suppressor genes, causes rapid regression of tumors that...

BY Sarah Bronson

A new class of drugs has redefined treatment for patients with myeloproliferative neoplasms by easing their symptom burden while extending...

BY Ron Gilmore

A protein kinase or enzyme known as PKM2 has proven to control cell division, potentially providing a molecular basis for tumor diagnosis...

BY MD Anderson staff

A story published last week in the Wall Street Journal reveals how immune checkpoint blockade is overcoming metastatic disease for a significant...

BY MD Anderson staff

Why haven't we cured cancer?

Hope for the possibility of a cure has existed as long as the disease. But when will it occur and what...

BY Ron Gilmore

Their responsibilities may range from exploring the intricacies of biostatistics to bringing new drugs more rapidly to the patient, but eight...

BY Ron Gilmore

Two leaders at MD Anderson Cancer Center have been elected to the Institute of Medicine (IOM) of the National Academies in recognition of...

BY Ron Gilmore

Federal Express and UPS are no match for the human body when it comes to distribution. There exists in cancer biology an impressive packaging...

BY La Chanda Ricks

“Is it possible to make cancer history?”

That’s a question Ethiopian President Mulatu Teshome asked during a recent visit to MD Anderson...

BY Ron Gilmore

New research at MD Anderson Cancer Center has found that oxygen-deprived RNA molecules lead to tumor progression.

As tumors grow, they...

BY Scott Merville

Improved surgical outcomes for ovarian cancer patients, expanded potential impact for new drugs and a novel family outreach program to head...

BY MD Anderson staff

"The only drug that works is a drug that a patient can afford."

That's what Hagop Kantarjian, M.D., told "60 Minutes...

BY Stephanie Deming

Innovative clinical trials that assign patients to treatment arms based on tumor biomarkers could lead to increased treatment options for...

BY Scott Merville

Known cancer-driving genomic aberrations in localized lung cancer appear to be so consistently present across tumors that a single biopsy...

BY MD Anderson staff

During MD Anderson’s recent Moon Shots Program event, a new clinical trial aimed at detecting lung cancer at an earlier stage was highlighted...

BY Laura Sussman

Removal of the entire lobe of lung may offer patients with early-stage lung cancer better overall survival when compared with a partial resection...

BY Ronda Wendler

Since the 1940s, Pap tests have been successfully detecting cervical cancer in its early stages, before it has a chance to spread. When caught...

BY Ron Gilmore

Exosomes — tiny, virus-size particles released by cancer cells — can bioengineer micro-RNA (miRNA) molecules resulting in tumor growth. They...

BY Jim Newman

This fall, officials with the Centers for Medicare and Medicaid Services (CMS) are debating the pros and cons of using low-dose CT scans to...

BY Ron Gilmore

MD Anderson scientists have discovered mutations in a gene that allow tumors to form and grow.

In this month’s issue of Cancer Cell...

BY Ron Gilmore

Want to understand why cancer cells metastasize? Think of Sparta.

Ancient Greek warriors were fed a special diet that better prepared...

BY Ron Gilmore

To speed the development of new cancer drugs, Bristol-Myers Squibb and MD Anderson are teaming up to conduct clinical trials of several new...

BY Scott Merville

Knock out a mutated gene that’s a driving force behind pancreatic cancer and a few cancer cells quietly remain behind, where they hunker down...

BY Laura Sussman

A new breast cancer vaccine candidate, (GP2), provides further evidence of the potential of immunotherapy in preventing disease recurrence...

BY Ron Gilmore

MD Anderson faculty received more than $25 million last month from the Cancer Prevention and Research Institute of Texas (CPRIT) to support...

BY Will Fitzgerald

A tailor-made suit sewn to fit a customer’s exact measurements almost always fits better than one purchased “off the rack.”

Researchers...

BY Ron Gilmore

Twist, Snail, Slug. They may sound like words in a children’s nursery rhyme, but they are actually the exotic names given to proteins that...

BY Katrina Burton

When a man is diagnosed with prostate cancer, a host of tools can be used to determine the type and extent of his disease. These tools include...

BY Ron Gilmore

Stephen Hahn, M.D., an international leader in the field of radiation oncology, has been named division head of Radiation Oncology and chair...

BY Laura Sussman

Breast conserving therapy (BCT) may offer better survival rates over mastectomy to women with early-stage, hormone-receptor positive disease...

BY Ron Gilmore

Parents of twins often tell them apart through subtle differences such as facial expression, moles, voice tone and gait. Similarly, physicians...

BY Jim Newman

Summer can be a quiet time at academic institutions, but things have been highly eventful for MD Anderson’s Breast Medical Oncology Department...

BY Sarah Bronson

The main side effects of cytotoxic chemotherapy are notorious. But the side effects of newer, targeted molecular agents are less well known...

BY La Chanda Ricks

MD Anderson Cancer Center has announced a partnership with Hospital Israelita Albert Einstein (HIAE) to pioneer multidisciplinary patient...

BY Scott Merville

Circulating tumor cells spread ovarian cancer through the bloodstream, homing in on a sheath of abdominal fatty tissue where it can grow and...

BY Will Fitzgerald

New research from MD Anderson Cancer Center is shedding light on the important role a diagnosing urologist plays in determining whether older...

BY Ron Gilmore

Alas, the thankless pseudogene.

Dysfunctional, unloved and seemingly of little use, these poor-cousin relatives...

BY MD Anderson

Dear colleagues,

I’m delighted to share with you Cancer Frontline from The University of Texas MD Anderson Cancer Center.

As...

BY Ron Gilmore

Just as no two people possess the same genetic makeup, a recent study has shown that no two single tumor cells in breast cancer patients have...

BY Katrina Burton

Effective new drugs and screening would make hepatitis C a rare disease by 2036, according to a computer simulation conducted by MD Anderson...

BY MD Anderson

MD Anderson Cancer Center is ranked No. 2 in cancer care by the U.S. News & World Report’s annual “Best Hospitals” survey.

Since...

BY Ronda Wendler

Seven postdoctoral research fellows who represent some of the country’s best cancer research trainees visited MD Anderson in June to participate...

BY MD Anderson

How can technological innovation help end cancer?

That's the question IBM and MD Anderson Cancer Center recently posed when they teamed...

BY Katrina Burton

More than 50 years after the first Surgeon General’s report on smoking definitively linked cigarettes and lung cancer, the world remains plagued...

BY Ron Gilmore

Scientists have long believed that obese women who develop a form of breast cancer fueled by the female hormone estrogen are more likely to...

BY Judy Overton and Jeanie Woodruff

Researchers at MD Anderson believe the diabetes drug metformin, the most widely used prescription drug in the world, can protect against chemotherapy-induced...

BY MD Anderson

An MD Anderson researcher has been awarded for his work leading to an entirely new way to treat cancer.

James Allison, Ph.D., chair...

BY Ron Gilmore

Receiving donor stem cells can be a life-saving treatment for patients with cancers of the blood or bone marrow such as leukemia, multiple...

BY Ron Gilmore

How will any one patient fare during and after cancer treatment? It’s a question with no easy answer.

But a mega-database known as...

BY Laura Sussman

African-American women with early-stage, invasive breast cancer were 12% less likely than Caucasian women with the same diagnosis to receive...

BY Katrina Burton

More than 50 years after the first Surgeon General’s report on smoking definitively linked cigarettes and lung cancer, the world remains plagued...

BY Will Fitzgerald

When Steven Frank, M.D., tackled a decades-old problem plaguing the field of prostate brachytherapy, he found himself in unchartered waters...

BY MD Anderson

Researchers from the MD Anderson Cancer Center found that 93% of head and neck cancer patients treated with multi-field optimization intensity...

BY Laura Sussman

Oncologists have a new understanding of the toxicity levels of specific chemotherapy regimens used for women with early stage breast cancer...

BY Scott Merville

Fibrous tissue that was long suspected of making pancreatic cancer worse actually supports an immune attack that slows tumor progression but...

BY Katrina Burton

Researchers at MD Anderson Cancer Center, in collaboration with the University of Utah and other institutions, have developed a powerful tool...

BY MD Anderson staff

Findings presented at the American Society of Clinical Oncology’s recent annual meeting offer new hope for preserving fertility in a select...

BY Scott Merville

An annotated database of actionable cancer genes, compiled by researchers at The University of Texas MD Anderson Cancer Center, has gone live...

BY Scott Merville

Scientists have found a way to target elusive cells that suppress immune response by depleting them with peptides that spare other important...

BY Ron Gilmore

Each year, roughly 200,000 blood transfusions are given at MD Anderson Cancer Center. Some patients experience negative reactions to the transfusions...

BY Julie Penne

For the second time in five years, MD Anderson’s Pain Management Center has been awarded the American Pain Society’s highest honor, making...

BY MD Anderson

Collaborations are crucial to making significant advancements toward ending cancer. Creating a worldwide network of basic, translational,...

BY MD Anderson

MD Anderson Cancer Center is expanding its efforts to combat lung cancer and other diseases. And an important piece of this initiative will...

BY MD Anderson

The following opinion piece includes the collective thoughts of several MD Anderson prevention researchers

Recently, the Food and Drug...

BY Laura Sussman

Advancements in imaging have dramatically altered all aspects of cancer care — from diagnosis and treatment to surveillance and prevention...

BY MD Anderson Staff

While many times, the achievements of senior faculty members receive the greatest attention, MD Anderson is also taking steps to highlight...

BY Scott Merville

A newly approved drug for the treatment of chronic lymphocytic leukemia (CLL), studied in clinical trials at MD Anderson, is showing significant...

BY MD Anderson Staff

In 2011, the MD Anderson Cancer Center received a $150 million gift — the largest in the history of the institution — from the Khalifa Bin...

BY MD Anderson

The G.H.A. Clowes Memorial Award is the oldest honor bestowed on a researcher by the American Association for Cancer Research. It's been given...

BY MD Anderson

The promise of immunotherapy, drugs that stimulate the body's immune system to fight cancer, can be witnessed by observing the string of development...

BY MD Anderson

Additional presentations of note at this year's American Association for Cancer Research Annual Meeting:

Reclassifying low-grade brain...

BY Scott Merville

The 54th annual meeting of the American Association for Cancer Research opens this morning in San Diego with educational sessions and workshops...

BY Will Fitzgerald

Women who underwent a mastectomy as part of their treatment for breast cancer are increasingly opting for reconstructive surgery, according...

BY MD Anderson Staff

The goal of harnessing the power of one's immune system to target and kill cancer cells just got a boost. New research from MD Anderson has...

BY Scott Merville

The U.S. Food and Drug Administration today approved ibrutinib as a single treatment for chronic lymphocytic leukemia patients with relapsed...

BY Sarah Adai

Over the past few decades it has become increasingly clear that epigenetic changes - heritable changes in the cell that do not result from...

BY Will Fitzgerald

In the largest expressive writing trial conducted on an oncology population, researchers from MD Anderson found those patients who recorded...